Clinical trial
Gait Evaluation in Multiple Sclerosis Patients Treated With Glatiramer Acetate
NCT00331747 · Sheba Medical Center, Other · Unknown status
Key facts
| NCT number | NCT00331747 |
|---|---|
| Title | Gait Evaluation in Multiple Sclerosis Patients Treated With Glatiramer Acetate |
| Official title | Three Dimensional Gait Evaluation in Relapsing Remitting Multiple Sclerosis Patients Treated With Glatiramer Acetate |
| Lead sponsor | Sheba Medical Center, Other |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Multiple Sclerosis |
| Intervention type | Drug |
| Interventions | Glatiramer acetate |
| Enrollment | 20 |
| Start date | May 1, 2006 |
| First posted | May 31, 2006 |
| Last update posted | Jul 7, 2006 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: